Plasma presepsin level predicts acute kidney injury in patients with sepsis in the emergency department. Issue 28 (15th July 2022)

• Record Type: Journal Article
• Authors: Kim, Sin Young; Hong, Dae Young; Lee, Kyeong Ryong; Paik, Jin Hui; Jung, Hyun Min
• Is Part Of: Medicine. Volume 101:Issue 28(2022)
• Page Start: e29919
• Publication Date: 2022-07-15
• Subjects: acute kidney injury -- biomarkers -- presepsin -- procalcitonin -- sepsis; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000029919
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Acute kidney injury (AKI) is a common complication in patients with sepsis. We evaluated the potential prognostic value of plasma presepsin to predict AKI in patients with sepsis in the emergency department. A total of 193 patients diagnosed with sepsis based on the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) were included in this observational study. AKI was defined according to the Kidney Disease Improving Global Outcomes clinical practice guideline. Plasma presepsin levels were measured on admission to the emergency department. We compared plasma presepsin levels between patients who did and those who did not develop AKI. AKI occurred in 100 (51.8%) patients. The median plasma presepsin level was significantly higher in patients with AKI than in those without AKI (1061 pg/mL vs 495 pg/mL, P <.001). Plasma presepsin levels were significantly increased in patients with AKI stage 3 compared with those with AKI stages 1 and 2 ( P =.001). The area under the curve of presepsin for predicting AKI was 0.793 (95% confidence interval: 0.729–0.848). The optimal presepsin cutoff value for predicting AKI was >572 pg/mL, with a sensitivity of 77.0% and specificity of 81.7%. Plasma presepsin level is a valuable biomarker for the prediction of AKI in patients with sepsis in the emergency department.